Evidence-Based Medicine Guidelines
Dopamine agonists for preventing ovarian hyperstimulation syndrome
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Dopamine Agonists for Preventing Ovarian Hyperstimulation Syndrome." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/1305077/all/_________Dopamine_agonists_for_preventing_ovarian_hyperstimulation_syndrome______.
Dopamine agonists for preventing ovarian hyperstimulation syndrome. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305077/all/_________Dopamine_agonists_for_preventing_ovarian_hyperstimulation_syndrome______. Accessed October 3, 2023.
Dopamine agonists for preventing ovarian hyperstimulation syndrome. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305077/all/_________Dopamine_agonists_for_preventing_ovarian_hyperstimulation_syndrome______
Dopamine Agonists for Preventing Ovarian Hyperstimulation Syndrome [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 October 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/1305077/all/_________Dopamine_agonists_for_preventing_ovarian_hyperstimulation_syndrome______.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Dopamine agonists for preventing ovarian hyperstimulation syndrome
ID - 1305077
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/1305077/all/_________Dopamine_agonists_for_preventing_ovarian_hyperstimulation_syndrome______
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
